查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings Inc. Common Stock | 4.52 2026-12-31 | 3.38 – 5.35 | 4 | +0.59% | +2.99% | +1.07% | 0 / 2 | $1.02B |
| TMO Thermo Fisher Scientific Inc Common Stock | 25.11 2026-12-31 | 24.88 – 25.26 | 25 | +1.03% | +1.02% | +0.92% | 2 / 1 | $47.84B |
| IART Integra LifeSciences Holdings Corporation Common Stock | 2.46 2026-12-31 | 2.41 – 2.5 | 12 | +0.29% | +0.29% | +4.52% | 0 / 0 | $1.67B |
| SAIC Science Applications International Corporation Common Stock | 10.18 2027-01-31 | 9.9 – 10.55 | 10 | +0.08% | +0.26% | +5.73% | 3 / 0 | $7.19B |
| SCI Service Corporation International Common Stock | 4.13 2026-12-31 | 4.07 – 4.24 | 6 | +0.16% | +0.16% | -1.05% | 0 / 4 | $4.43B |
| PCRX Pacira BioSciences Inc. Common Stock | 2.88 2026-12-31 | 2.74 – 2.98 | 6 | 0.00% | 0.00% | +9.30% | 6 / 1 | $767.79M |
| MSCI MSCI Inc. Common Stock | 19.66 2026-12-31 | 19.3 – 19.89 | 16 | -0.26% | -0.13% | +0.14% | 3 / 0 | $3.51B |
| EW Edwards Lifesciences Corporation Common Stock | 3 2026-12-31 | 2.96 – 3.05 | 28 | -0.26% | -0.30% | -0.26% | 1 / 1 | $6.76B |
| BSX Boston Scientific Corporation Common Stock | 3.31 2026-12-31 | 3.28 – 3.37 | 23 | -1.64% | -1.73% | -2.17% | 0 / 16 | $21.4B |
| NBIX Neurocrine Biosciences Inc. Common Stock | 9.93 2026-12-31 | 6.2 – 18.18 | 16 | -0.19% | -2.46% | +3.10% | 1 / 0 | $3.79B |
| ABSI Absci Corporation Common Stock | -0.78 2026-12-31 | -0.96 – -0.59 | 9 | — | — | — | 3 / 1 | $5.67M |
| ACHV Achieve Life Sciences Inc. Common Shares | -0.68 2026-12-31 | -0.95 – -0.52 | 9 | — | — | — | 7 / 0 | $0 |
| ALMR Alamar Biosciences Inc. Common Stock | -1.46 2026-12-31 | -1.65 – -1.24 | 4 | — | — | — | 0 / 0 | $113.22M |
| ANRO Alto Neuroscience Inc. Common Stock | -3.15 2026-12-31 | -3.72 – -2.58 | 6 | — | — | — | 0 / 1 | $0 |
| AURA Aura Biosciences Inc. Common Stock | -1.6 2026-12-31 | -2 – -1.41 | 4 | — | — | — | 2 / 1 | $0 |
| BHST BioHarvest Sciences Inc. Common Stock | -0.41 2026-12-31 | -0.46 – -0.35 | 4 | — | — | — | 0 / 3 | $42.89M |
| CAI Caris Life Sciences Inc. Common Stock | 0.13 2026-12-31 | 0 – 0.33 | 10 | — | — | — | 4 / 6 | $1B |
| CLRB Cellectar Biosciences Inc. Common Stock | -2.17 2026-12-31 | -2.85 – -1.47 | 4 | — | — | — | 1 / 0 | $0 |
| COGT Cogent Biosciences Inc. Common Stock | -2.26 2026-12-31 | -2.7 – -1.96 | 10 | — | — | — | 2 / 7 | $9.9M |
| CRBU Caribou Biosciences Inc. Common Stock | -1.25 2026-12-31 | -1.36 – -1.15 | 3 | — | — | — | 0 / 1 | $25.66M |
| CSTL Castle Biosciences Inc. Common Stock | -1.42 2026-12-31 | -1.77 – -0.84 | 9 | — | — | — | 3 / 5 | $352.29M |
| DARE Dare Bioscience Inc. Common Stock | -0.95 2026-12-31 | -1.37 – -0.57 | 3 | — | — | — | 2 / 0 | $2.11M |
| DTIL Precision BioSciences Inc. Common Stock | -2.49 2026-12-31 | -3.12 – -1.7 | 3 | — | — | — | 1 / 0 | $18.81M |
| FBRX Forte Biosciences Inc. Common Stock | -3.83 2026-12-31 | -4.48 – -3.22 | 5 | — | — | — | 4 / 1 | $0 |
| GILD Gilead Sciences Inc. Common Stock | -0.75 2026-12-31 | -1.05 – -0.26 | 27 | — | — | — | 3 / 0 | $30.42B |
| IDYA IDEAYA Biosciences Inc. Common Stock | -4.29 2026-12-31 | -5 – -3.49 | 13 | — | — | — | 2 / 13 | $34.08M |
| KOD Kodiak Sciences Inc Common Stock | -3.74 2026-12-31 | -4.03 – -3.48 | 6 | — | — | — | 4 / 0 | $0 |
| MBX MBX Biosciences Inc. Common Stock | -2.71 2026-12-31 | -3.22 – -2.32 | 8 | — | — | — | 7 / 2 | $0 |
| MRVI Maravai LifeSciences Holdings Inc. Class A Common Stock | -0.11 2026-12-31 | -0.17 – -0.06 | 8 | — | — | — | 2 / 0 | $210.43M |
| MSLE Satellos Bioscience Inc. Common Stock | -2.52 2026-12-31 | -4.46 – -1.67 | 4 | — | — | — | 1 / 1 | $0 |
| PACB Pacific Biosciences of California Inc. Common Stock | -0.51 2026-12-31 | -0.52 – -0.49 | 5 | — | — | — | 0 / 1 | $167.43M |
| RCUS Arcus Biosciences Inc. Common Stock | -3.48 2026-12-31 | -4.88 – -2.63 | 7 | — | — | — | 1 / 2 | $85.06M |
| ROIV Roivant Sciences Ltd. Common Shares | -1.5 2027-03-31 | -1.96 – -1.18 | 3 | — | — | — | 0 / 3 | $54.65M |
| SGHT Sight Sciences Inc. Common Stock | -0.6 2026-12-31 | -0.81 – -0.36 | 5 | — | — | — | 2 / 1 | $86.08M |
| SGMT Sagimet Biosciences Inc. Series A Common Stock | -1.22 2026-12-31 | -1.51 – -0.89 | 9 | — | — | — | 6 / 1 | $0 |
| SKYE Skye Bioscience Inc. Common Stock | -1.05 2026-12-31 | -1.44 – -0.63 | 5 | — | — | — | 3 / 1 | $0 |
| SLDB Solid Biosciences Inc. Common Stock | -1.96 2026-12-31 | -2.51 – -1.67 | 13 | — | — | — | 1 / 12 | $0 |
| SNTI Senti Biosciences Holdings Inc. Common Stock | -1.16 2026-12-31 | -1.38 – -0.78 | 3 | — | — | — | 0 / 0 | $33.33K |
| SPRB Spruce Biosciences Inc. Common Stock | -24.89 2026-12-31 | -33.25 – -20.39 | 7 | — | — | — | 2 / 2 | $0 |
| TLSI TriSalus Life Sciences Inc. Common Stock | -0.29 2026-12-31 | -0.34 – -0.25 | 4 | — | — | — | 0 / 1 | $52.4M |
| TYRA Tyra Biosciences Inc. Common Stock | -2.57 2026-12-31 | -2.82 – -2.31 | 14 | — | — | — | 1 / 0 | $0 |
| WVE Wave Life Sciences Ltd. Ordinary Shares | -0.84 2026-12-31 | -1.33 – 1.64 | 12 | — | — | — | 9 / 0 | $59.13M |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。